227 related articles for article (PubMed ID: 18729468)
1. Combination chemotherapy and photodynamic therapy with fab' fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cells.
Hongrapipat J; Kopecková P; Liu J; Prakongpan S; Kopecek J
Mol Pharm; 2008; 5(5):696-709. PubMed ID: 18729468
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antitumor activity of combinations of free and HPMA copolymer-bound drugs.
Hongrapipat J; Kopecková P; Prakongpan S; Kopecek J
Int J Pharm; 2008 Mar; 351(1-2):259-70. PubMed ID: 18029122
[TBL] [Abstract][Full Text] [Related]
3. Polymerizable Fab' antibody fragments for targeting of anticancer drugs.
Lu ZR; Kopecková P; Kopecek J
Nat Biotechnol; 1999 Nov; 17(11):1101-4. PubMed ID: 10545917
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of cytotoxicity in human ovarian carcinoma cells exposed to free Mce6 or HPMA copolymer-Mce6 conjugates.
Tijerina M; Kopecková P; Kopecek J
Photochem Photobiol; 2003 Jun; 77(6):645-52. PubMed ID: 12870851
[TBL] [Abstract][Full Text] [Related]
5. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro.
Omelyanenko V; Gentry C; Kopecková P; Kopecek J
Int J Cancer; 1998 Feb; 75(4):600-8. PubMed ID: 9466663
[TBL] [Abstract][Full Text] [Related]
6. Cooperativity between free and N-(2-hydroxypropyl) methacrylamide copolymer bound adriamycin and meso-chlorin e6 monoethylene diamine induced photodynamic therapy in human epithelial ovarian carcinoma in vitro.
Lu JM; Peterson CM; Guo-Shiah J; Gu ZW; Peterson CA; Straight RC; Kopecek J
Int J Oncol; 1999 Jul; 15(1):5-16. PubMed ID: 10375588
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments.
Shiah JG; Sun Y; Peterson CM; Straight RC; Kopecek J
Clin Cancer Res; 2000 Mar; 6(3):1008-15. PubMed ID: 10741728
[TBL] [Abstract][Full Text] [Related]
8. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. influence of the method of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro.
Omelyanenko V; Kopecková P; Gentry C; Shiah JG; Kopecek J
J Drug Target; 1996; 3(5):357-73. PubMed ID: 8866655
[TBL] [Abstract][Full Text] [Related]
9. Preparation and biological evaluation of polymerizable antibody Fab' fragment targeted polymeric drug delivery system.
Lu ZR; Shiah JG; Kopecková P; Kopecek J
J Control Release; 2001 Jul; 74(1-3):263-8. PubMed ID: 11489505
[TBL] [Abstract][Full Text] [Related]
10. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line.
Kunath K; Kopecková P; Minko T; Kopecek J
Eur J Pharm Biopharm; 2000 Jan; 49(1):11-5. PubMed ID: 10613922
[TBL] [Abstract][Full Text] [Related]
11. Novel HPMA copolymer-bound constructs for combined tumor and mitochondrial targeting.
Cuchelkar V; Kopecková P; Kopecek J
Mol Pharm; 2008; 5(5):776-86. PubMed ID: 18767867
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of HPMA copolymer-aminopropylgeldanamycin conjugates.
Kasuya Y; Lu ZR; Kopecková P; Minko T; Tabibi SE; Kopecek J
J Control Release; 2001 Jul; 74(1-3):203-11. PubMed ID: 11489496
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy and photodynamic therapy of targetable N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin/mesochlorin e(6)-OV-TL 16 antibody immunoconjugates.
Shiah JG; Sun Y; Kopecková P; Peterson CM; Straight RC; Kopecek J
J Control Release; 2001 Jul; 74(1-3):249-53. PubMed ID: 11489502
[TBL] [Abstract][Full Text] [Related]
14. Correlation of subcellular compartmentalization of HPMA copolymer-Mce6 conjugates with chemotherapeutic activity in human ovarian carcinoma cells.
Tijerina M; Kopecková P; Kopecek J
Pharm Res; 2003 May; 20(5):728-37. PubMed ID: 12751627
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of multivalent branched HPMA copolymer-Fab' conjugates targeted to the B-cell antigen CD20.
Johnson RN; Kopecková P; Kopecek J
Bioconjug Chem; 2009 Jan; 20(1):129-37. PubMed ID: 19154157
[TBL] [Abstract][Full Text] [Related]
16. N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation.
Searle F; Gac-Breton S; Keane R; Dimitrijevic S; Brocchini S; Sausville EA; Duncan R
Bioconjug Chem; 2001; 12(5):711-8. PubMed ID: 11562189
[TBL] [Abstract][Full Text] [Related]
17. Design of novel bioconjugates for targeted drug delivery.
Lu ZR; Shiah JG; Sakuma S; Kopecková P; Kopecek J
J Control Release; 2002 Jan; 78(1-3):165-73. PubMed ID: 11772458
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution of free and N-(2-hydroxypropyl)methacrylamide copolymer-bound mesochlorin e(6) and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts.
Shiah JJ; Sun Y; Peterson CM; Kopecek J
J Control Release; 1999 Aug; 61(1-2):145-57. PubMed ID: 10469911
[TBL] [Abstract][Full Text] [Related]
19. Anti-CD20 multivalent HPMA copolymer-Fab' conjugates for the direct induction of apoptosis.
Chu TW; Yang J; Kopeček J
Biomaterials; 2012 Oct; 33(29):7174-81. PubMed ID: 22795544
[TBL] [Abstract][Full Text] [Related]
20. Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate.
Omelyanenko V; Kopecková P; Gentry C; Kopecek J
J Control Release; 1998 Apr; 53(1-3):25-37. PubMed ID: 9741911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]